Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 3Solid Tumors 2Pancreatic Neoplasms 2Lymphoma, Non-Hodgkin 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Spondylitis, Ankylosing 1Respiratory Tract Infections 1Respiratory Distress Syndrome 1Pneumonia 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1COVID-19 1Arthritis, Rheumatoid 1

Interventions

Paclitaxel 4tocilizumab 2pembrolizumab 2atezolizumab 2zansecimab 1tivozanib 1temsirolimus 1spartalizumab 1ridaforolimus 1parsaclisib 1olaparib 1obinutuzumab 1motesanib diphosphate 1liposomal doxorubicin 1itacitinib 1epacadostat 1durvalumab 1birinapant 1Vertebroplasty 1Temozolomide 1TAK-981 1Ramucirumab 1Panobinostat 1Oxaliplatin 1Leucovorin 1Kyphoplasty 1IT-101 1INCB039110 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Solid Tumors × tocilizumab × Clear all
NCT05129280 2023-08-04

A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors

Hoffmann-La Roche

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Solid Tumors

NCT03539484 2020-09-03

A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors

Hoffmann-La Roche

Phase 1 Terminated
26 enrolled 30 charts
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡